Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

GFR Measurement With Contrast-enhanced Dynamic MRI

NCT: NCT00614081 · COMPLETED

NCT IDNCT00614081
StatusCOMPLETED
Start Date2008-01
Completion2013-03

Brief Summary

The aim of the study is to optimize and validate this MR-based GFR measurement in patients with a renal transplant, compared with the reference method, the Cr51- EDTA method: to select the most accurate combination of post-treatment of renal MR images and then evaluate its intra- and inter-rater reliability.

Frequently Asked Questions

What is GFR Measurement With Contrast-enhanced Dynamic MRI?

GFR Measurement With Contrast-enhanced Dynamic MRI is a clinical trial registered under NCT00614081. Current status: COMPLETED.

What is the status of NCT00614081?

The current status of NCT00614081 (GFR Measurement With Contrast-enhanced Dynamic MRI) is: COMPLETED.

When did GFR Measurement With Contrast-enhanced Dynamic MRI start?

GFR Measurement With Contrast-enhanced Dynamic MRI started on 2008-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑